Doctor profile · Federal record
Dr. TRACEY JONES, CRNP
Hematology & Oncology Physician (CMS: NURSE PRACTITIONER) · MOBILE, AL
- NPI 1134171887
- Accepts Medicare
- MIPS 83.9 / 100 · 2023
- 26 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6701 AIRPORT BLVD, BLDG B T-LEVEL
MOBILE, AL 36608
(251) 625-6896
fax (251) 625-6897 - Mailing address
-
29653 ANCHOR CROSS BLVD
DAPHNE, AL 365269594
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- June 11, 2015
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Alabama #1075963
- Medicaid
- AL #891017040
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134171887. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
73
Distinct HCPCS
3
Medicare allowed
$6,223
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 40 | 30 | $101 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 20 | 16 | $71 | |
38222 |
Biopsy and aspiration of bone marrow sample for diagnosis | 13 | 13 | $60 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 768. This provider delivers 0.1× the peer median.Open Payments
Industry payments received
All-time total
$2,455
Transactions
94
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $326.97 | |
| Merck Sharp & Dohme LLC | 11 | $248.41 | |
| Janssen Biotech, Inc. | 9 | $174.81 | |
| AstraZeneca Pharmaceuticals LP | 8 | $152.95 | |
| Genentech USA, Inc. | 8 | $143.01 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $129.44 | |
| PFIZER INC. | 8 | $128.81 | |
| Alexion Pharmaceuticals, Inc. | 2 | $127.65 | |
| Celgene Corporation | 6 | $124.39 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $99.95 | |
| ABBVIE INC. | 4 | $92.89 | |
| GENZYME CORPORATION | 4 | $88.70 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $81.05 | |
| Stemline Therapeutics Inc. | 3 | $71.14 | |
| Daiichi Sankyo Inc. | 3 | $69.55 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
109
Patients
24
Total drug cost
$2,886
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 65 | 24 | $1,939 |
| Letrozole | Generic | 32 | 0 | $643 |
| Prochlorperazine Maleate | Generic | 12 | 0 | $303 |